These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8463247)

  • 1. Interleukin-8 antagonists generated by N-terminal modification.
    Moser B; Dewald B; Barella L; Schumacher C; Baggiolini M; Clark-Lewis I
    J Biol Chem; 1993 Apr; 268(10):7125-8. PubMed ID: 8463247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptor recognition and specificity of interleukin-8 is determined by residues that cluster near a surface-accessible hydrophobic pocket.
    Hammond ME; Shyamala V; Siani MA; Gallegos CA; Feucht PH; Abbott J; Lapointe GR; Moghadam M; Khoja H; Zakel J; Tekamp-Olson P
    J Biol Chem; 1996 Apr; 271(14):8228-35. PubMed ID: 8626516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemokine antagonists that discriminate between interleukin-8 receptors. Selective blockers of CXCR2.
    Jones SA; Dewald B; Clark-Lewis I; Baggiolini M
    J Biol Chem; 1997 Jun; 272(26):16166-9. PubMed ID: 9195914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1H NMR studies of interleukin 8 analogs: characterization of the domains essential for function.
    Rajarathnam K; Clark-Lewis I; Sykes BD
    Biochemistry; 1994 May; 33(21):6623-30. PubMed ID: 8204599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet factor 4 binds to interleukin 8 receptors and activates neutrophils when its N terminus is modified with Glu-Leu-Arg.
    Clark-Lewis I; Dewald B; Geiser T; Moser B; Baggiolini M
    Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3574-7. PubMed ID: 8475106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutrophil-activating peptide 2 and gro/melanoma growth-stimulatory activity interact with neutrophil-activating peptide 1/interleukin 8 receptors on human neutrophils.
    Moser B; Schumacher C; von Tscharner V; Clark-Lewis I; Baggiolini M
    J Biol Chem; 1991 Jun; 266(16):10666-71. PubMed ID: 2037605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High- and low-affinity binding of GRO alpha and neutrophil-activating peptide 2 to interleukin 8 receptors on human neutrophils.
    Schumacher C; Clark-Lewis I; Baggiolini M; Moser B
    Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10542-6. PubMed ID: 1438244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of transcripts for two interleukin 8 receptors in human phagocytes, lymphocytes and melanoma cells.
    Moser B; Barella L; Mattei S; Schumacher C; Boulay F; Colombo MP; Baggiolini M
    Biochem J; 1993 Aug; 294 ( Pt 1)(Pt 1):285-92. PubMed ID: 8363581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The CXC chemokines growth-regulated oncogene (GRO) alpha, GRObeta, GROgamma, neutrophil-activating peptide-2, and epithelial cell-derived neutrophil-activating peptide-78 are potent agonists for the type B, but not the type A, human interleukin-8 receptor.
    Ahuja SK; Murphy PM
    J Biol Chem; 1996 Aug; 271(34):20545-50. PubMed ID: 8702798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-activity relationships of interleukin-8 determined using chemically synthesized analogs. Critical role of NH2-terminal residues and evidence for uncoupling of neutrophil chemotaxis, exocytosis, and receptor binding activities.
    Clark-Lewis I; Schumacher C; Baggiolini M; Moser B
    J Biol Chem; 1991 Dec; 266(34):23128-34. PubMed ID: 1744111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthetic hexa- and heptapeptides that inhibit IL-8 from binding to and activating human blood neutrophils.
    Hayashi S; Kurdowska A; Miller EJ; Albright ME; Girten BE; Cohen AB
    J Immunol; 1995 Jan; 154(2):814-24. PubMed ID: 7814885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotactic activity and receptor binding of neutrophil attractant/activation protein-1 (NAP-1) and structurally related host defense cytokines: interaction of NAP-2 with the NAP-1 receptor.
    Leonard EJ; Yoshimura T; Rot A; Noer K; Walz A; Baggiolini M; Walz DA; Goetzl EJ; Castor CW
    J Leukoc Biol; 1991 Mar; 49(3):258-65. PubMed ID: 1997632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Granulocyte chemotactic protein 2 acts via both IL-8 receptors, CXCR1 and CXCR2.
    Wolf M; Delgado MB; Jones SA; Dewald B; Clark-Lewis I; Baggiolini M
    Eur J Immunol; 1998 Jan; 28(1):164-70. PubMed ID: 9485196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CXC chemokines bind to unique sets of selectivity determinants that can function independently and are broadly distributed on multiple domains of human interleukin-8 receptor B. Determinants of high affinity binding and receptor activation are distinct.
    Ahuja SK; Lee JC; Murphy PM
    J Biol Chem; 1996 Jan; 271(1):225-32. PubMed ID: 8550564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of Tyr13 and Lys15 of interleukin-8 in the high affinity interaction with the interleukin-8 receptor type A.
    Schraufstätter IU; Ma M; Oades ZG; Barritt DS; Cochrane CG
    J Biol Chem; 1995 May; 270(18):10428-31. PubMed ID: 7737976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ELR-CXC chemokine receptor antagonism targets inflammatory responses at multiple levels.
    Zhao X; Town JR; Li F; Zhang X; Cockcroft DW; Gordon JR
    J Immunol; 2009 Mar; 182(5):3213-22. PubMed ID: 19234219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure and functional expression of a human interleukin-8 receptor.
    Holmes WE; Lee J; Kuang WJ; Rice GC; Wood WI
    Science; 1991 Sep; 253(5025):1278-80. PubMed ID: 1840701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amino terminus of the interleukin-8 receptor is a major determinant of receptor subtype specificity.
    LaRosa GJ; Thomas KM; Kaufmann ME; Mark R; White M; Taylor L; Gray G; Witt D; Navarro J
    J Biol Chem; 1992 Dec; 267(35):25402-6. PubMed ID: 1281158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-Terminal region is responsible for chemotaxis-inducing activity of flounder IL-8.
    Kurata O; Wada S; Matsuyama T; Sakai T; Takano T
    Fish Shellfish Immunol; 2014 Jun; 38(2):361-6. PubMed ID: 24751922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular characterization of receptors for human interleukin-8, GRO/melanoma growth-stimulatory activity and neutrophil activating peptide-2.
    Cerretti DP; Kozlosky CJ; Vanden Bos T; Nelson N; Gearing DP; Beckmann MP
    Mol Immunol; 1993 Mar; 30(4):359-67. PubMed ID: 8384312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.